Price Chart: Singular Genomics Systems Inc (OMIC)

Singular Genomics Systems (OMIC) is developing the G4 high-precision genome sequencing system by implementing software and new reagents. Possessing moderate pricing power, the company attracts clients through the speed of analysis delivery, with the metric standing at 20.02. This historical price chart links these successes to partnerships with biotech centers focused on drug discovery. The business relies on the joint deployment of its technological platforms with scientists.

OMIC - Singular Genomics Corp Market Chart over the range 07/04/2022 - 03/01/2025

Singular Genomics Systems, Inc. (OMIC) - metric breakdowns and financial figures

- stock value and consensus price forecast:

Price Chart Singular Genomics Systems|OMIC - Average Forecast Price

- company stock exchange capitalization indicators:

Market Value Singular Genomics Systems, Inc.|OMIC - Real Price to Acquire Entire Company

- balance sheet equity data:

Book Value per Share Singular Genomics|OMIC - Book Valuation of Business|Market Capitalization to Book Value Ratio singulargenomics.com|OMIC - Cumulative Company Assets

- issuer credit burden and liquidity indicators:

Total Debt to Capital Singular Genomics Systems|OMIC - Long-Term Debt to Capital Ratio|Short-Term Debt to Equity Singular Genomics Systems Inc|OMIC - Company Aggregate Debt|Debts to Book Capitalization Singular Genomics Systems, Inc.|OMIC - Company Long-Term Debts|Company Short-Term Debt Singular Genomics|Quick Ratio singulargenomics.com

- earnings and market ratios statistics:

OMIC - Net Financial Result|Expected Profit Singular Genomics Systems|OMIC - Price to Earnings Multiple|Forward P/E Multiple Singular Genomics|OMIC - Price to Net Income Growth Ratio|Enterprise Value to EBITDA Ratio Singular Genomics Systems, Inc.|OMIC - Operating profit EBITDA|Earnings per share for the last twelve months Singular Genomics|OMIC - Earnings per share for the last twelve months|Quarterly EPS earnings growth singulargenomics.com|OMIC - Earnings growth in current year|Net earnings per share growth forecast for next year Singular Genomics Systems

Summary company analytics:Singular Genomics Systems

Price serves as the fundamental calculation component for all investment multiples, separating market speculation from the objective value of assets. By analyzing fluctuations in exchange quotes, an investor assesses the capitalization of Singular Genomics Systems (OMIC), which directly depends on the commercial success of their robotic DNA sequencing systems and the efficiency of microfluidics automation in laboratory processes.

Analysis of competing companies